LAURA STINSON: Open Payments
NPI 1801464995 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $305 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| PFIZER INC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Dynavax Technologies Corporation | 1 | $30 |
| Exact Sciences Corporation | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
Products named: TZIELD, JARDIANCE, CAPLYTA, Heplisav-B, Cologuard Collection Kit, PREVNAR 20, ELIQUIS, FARXIGA.
Industry payments across GA — which companies pay providers there.
